Skip to main content

Research

The Department of Pathology is deeply invested in scientific efforts to improve treatments in our field. Learn more about our department’s investigations below.

Message from the Vice Chair

"We are driven by a shared passion for discovery and a deep commitment to advancing human health through innovative research programs and collaborative partnerships among scientists and pathologists."

Peng Ji, MD, PhD
Vice Chair of Research 

Read Full Message

Areas of Research

Members of the Department of Pathology are defining the cellular and molecular basis of disease toward the development of new and improved strategies to diagnose and treat, inherited, acquired and infectious disorders. Learn more about the work being done in our labs.

Research Areas

Affiliated Research Centers and Institutes

The faculty members of Northwestern University Feinberg School of Medicine’s Department of Pathology are engaged in research within the department and throughout Northwestern Medicine and Northwestern University. Our work throughout the community, including director appointments, illustrate the importance we put on scientific collaboration.

Research Cores

Core facilities provide cost-efficient access of state-of-the-art equipment, the most current technologies and expert technical advice to individual scientists.

Learn more about our affiliated cores

Access Research Resources

Recent Publications

Rhabdoid Tumor of the Kidney and Soft Tissues: Results from National Wilms Tumor Study-5 and Children's Oncology Group Study AREN0321.

Geller JI, Renfro LA, Grundy PE, Perlman EJ, Kalapurakal JA, Ehrlich PF, Biegel J, Huff V, Warwick AB, Paulino A, Mullen EA, Daw NC, Hoffer FA, Tochner Z, Gow K, Gratias E, Ward DA, Anderson JR, Fernandez CV, Dome JS.

Pediatr Blood Cancer. 2025 Mar;72(3):e31490. doi: 10.1002/pbc.31490. Epub 2024 Dec 19.

Weight and Blood-Based Markers of Cachexia Predict Disability, Hospitalization and Worse Survival in Cancer Immunotherapy Patients.

Tran SD, Forrest NJ, Guggilla V, Perottino GM, Johnson JL, Sosman J, Roy I, Walunas TL.

J Cachexia Sarcopenia Muscle. 2025 Feb;16(1):e13685. doi: 10.1002/jcsm.13685.

Placental Pathology and Blood Pressure at Age 7: A Longitudinal Discordant Twin Analysis.

Freedman AA, Miller GE, Franklin AD, Keenan-Devlin LS, Gilman SE, Borders A, Khan SS, Ernst LM.

Arterioscler Thromb Vasc Biol. 2025 Feb;45(2):312-322. doi: 10.1161/ATVBAHA.124.321666. Epub 2024 Dec 19.

Genomic characterization and histologic analysis of uterine leiomyosarcoma arising from leiomyoma with bizarre nuclei.

Felicelli C, Lu X, Coty-Fattal Z, Feng Y, Yin P, Schipma MJ, Kim JJ, Jennings LJ, Bulun SE, Wei JJ.

J Pathol. 2025 Feb;265(2):211-225. doi: 10.1002/path.6379. Epub 2024 Dec 18.

Research culture influences in health and biomedical research: rapid scoping review and content analysis.

Uttley L, Falzon L, Byrne JA, Tricco AC, Munafò MR, Moher D, Stoeger T, Matandika L, Labbé C, Naudet F.

J Clin Epidemiol. 2025 Feb;178:111616. doi: 10.1016/j.jclinepi.2024.111616. Epub 2024 Nov 23.

Real World Outcome of High-Risk Multiple Myeloma: An Indian Tertiary Care Centre Experience.

Soni A, Rainchwar S, Singh R, Gupta DG, Tikare N, Halder R, Palatty RJ, Sheth VS, Agrawal N, Bhurani D, Panda T.

Clin Lymphoma Myeloma Leuk. 2025 Feb;25(2):e110-e119. doi: 10.1016/j.clml.2024.09.007. Epub 2024 Sep 22.

Recommended guidelines for screening for underlying malignancy in extramammary Paget's disease based on anatomic subtype.

Kibbi N, Owen JL, Worley B, Alam M; Extramammary Paget's Disease Guideline Study Group.

J Am Acad Dermatol. 2025 Feb;92(2):261-268. doi: 10.1016/j.jaad.2024.07.1531. Epub 2024 Oct 12.

Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC).

Gillessen S, Turco F, Davis ID, Efstathiou JA, Fizazi K, James ND, Shore N, Small E, Smith M, Sweeney CJ, Tombal B, Zilli T, Agarwal N, Antonarakis ES, Aparicio A, Armstrong AJ, Bastos DA, Attard G, Axcrona K, Ayadi M, Beltran H, Bjartell A, Blanchard P, Bourlon MT, Briganti A, Bulbul M, Buttigliero C, Caffo O, Castellano D, Castro E, Cheng HH, Chi KN, Clarke CS, Clarke N, de Bono JS, De Santis M, Duran I, Efstathiou E, Ekeke ON, El Nahas TIH, Emmett L, Fanti S, Fatiregun OA, Feng FY, Fong PCC, Fonteyne V, Fossati N, George DJ, Gleave ME, Gravis G, Halabi S, Heinrich D, Herrmann K, Hofman MS, Hope TA, Horvath LG, Hussain MHA, Jereczek-Fossa BA, Jones RJ, Joshua AM, Kanesvaran R, Keizman D, Khauli RB, Kramer G, Loeb S, Mahal BA, Maluf FC, Mateo J, Matheson D, Matikainen MP, McDermott R, McKay RR, Mehra N, Merseburger AS, Morgans AK, Morris MJ, Mrabti H, Mukherji D, Murphy DG, Murthy V, Mutambirwa SBA, Nguyen PL, Oh WK, Ost P, O'Sullivan JM, Padhani AR, Parker C, Poon DMC, Pritchard CC, Rabah DM, Rathkopf D, Reiter RE, Renard-Penna R, Ryan CJ, Saad F, Sade JP, Sandhu S, Sartor OA, Schaeffer E, Scher HI, Sharifi N, Skoneczna IA, Soule HR, Spratt DE, Srinivas S, Sternberg CN, Suzuki H… See abstract for full author list ➔

Eur Urol. 2025 Feb;87(2):157-216. doi: 10.1016/j.eururo.2024.09.017. Epub 2024 Oct 11.

Serum and tissue biomarkers of plasma cell-rich rejection in liver transplant recipients.

Saravanan N, Demetris A, Fiel MI, Harrington C, Khurram NA, Schiano TD, Levitsky J.

Am J Transplant. 2025 Feb;25(2):259-268. doi: 10.1016/j.ajt.2024.10.006. Epub 2024 Oct 9.

FGFR Inhibition in Urothelial Carcinoma.

Li R, Linscott J, Catto JWF, Daneshmand S, Faltas BM, Kamat AM, Meeks JJ, Necchi A, Pradere B, Ross JS, van der Heijden MS, van Rhijn BWG, Loriot Y.

Eur Urol. 2025 Feb;87(2):110-122. doi: 10.1016/j.eururo.2024.09.012. Epub 2024 Sep 30.

Be a part of our future discoveries.Giving

Follow Pathology on FacebookInstagram